uPAR is involved in chronic inflammatory and cardiovascular diseases, with clinical and experimental evidence implicating it in atherosclerosis and chronic obstructive pulmonary disease (COPD) via leukocyte recruitment, matrix metalloproteinase activation, and extracellular-matrix remodeling [40,41,42,43]. This evidence concerns the gene PLAUR and atherosclerosis.